Dr. Sadat Ozair, MD

Dr. Ozair practices at Glens Falls Hospital in Glens Falls, New York, part of Albany Med Health System.

Dr. Ozair's NPI, 1285796508, was assigned on December 14, 2006. Dr. Ozair graduated from Dow University of Health Sciences in 1998. Dr. Ozair holds New York license 262561.

Dr. Ozair's primary practice is Glens Falls Hospital, at 100 Park Street, Glens Falls, NY 12801 in Warren County. The practice phone is (518) 926-1000.

Dr. Ozair's primary practice is Glens Falls Hospital in Glens Falls, New York, part of Albany Med Health System. Dr. Ozair is also affiliated with Albany Medical Center. The medical group on file is Glens Falls Hospital. Dmand AI also links Dr. Ozair to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ozair practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ozair's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ozair is licensed in New York.

CMS data shows 200 Medicare services from Dr. Ozair across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $22,945 for them.

CMS counts 86 Medicare patients who saw Dr. Ozair in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ozair's median patient age at 63, with 58% women.

In 2024, Dr. Ozair wrote 339 Medicare Part D claims for 72 patients. 82% of them were for generic drugs. CMS names the drug for 199 of them, across 8 drugs with 11 or more claims each, at $58,786 in total drug cost. In 2023, CMS named 341 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Ozair for performance year 2024, reported through an alternative payment model (APM). CMS lists Dr. Ozair as offering telehealth.

Dmand AI links 4 papers to Dr. Ozair, published from 2018 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Cystectomy and Venous Thromboembolism. Dr. Ozair's most frequent co-authors are Khurshid Ahad Guru, MD, Umar Iqbal, MD and Dana Elizabeth Angelini, MD.

CMS Open Payments shows 120 general payments to Dr. Ozair from 34 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 58% of the total. Novartis Pharmaceuticals Corporation paid the most, $948.

Dr. Ozair graduated from Dow University of Health Sciences in 1998.